Gone for LifeSmarts. Back Next Wednesday – National Consumers League
We are busy running LifeSmarts over here.
We are busy running LifeSmarts over here.
Prices at the pump getting you down? Here are a few tips on getting your money’s worth when buying auto insurance:
The excitement is building at NCL as we finish the last-minute preparations for the 2008 National LifeSmarts Championship. This year we’re heading to Minneapolis, MN where teens from 29 states will compete. These state champs are sharp, emerging from more than 20,000 other students who answered more than 2.6 million questions in order to make it to Nationals.
Do you think you’re up to the challenge? Test your LifeSmarts skills.
What kind of personal information is not covered by any federal privacy law? (Answer will appear in a blog later this week.)
a. Titles of videos you rent
b. Items you buy at a supermarket
c. What you watch on cable television
By Reid Maki, NCL staff
As you bite into that juicy piece of fruit, you might want to think about the hidden cost of inexpensive American produce: the extensive use of chemical pesticides, some of which cause grievous harm to the workers who pick the fruit.
The potential dangers of pesticides were highlighted on March 24, when Ag-Mart, a Florida-based produce company, announced it was settling a civil suit brought by the parents of Carlos (“Carlitos”) Candelario Herrera, who was born in December 2004 without arms and legs.
Carlitos was one of three children born with major birth defects in a six-week period in 2005-2006 to farmworker parents who lived in Immokalee, Florida and who worked for Ag-mart in Florida and North Carolina. According to reports in the Palm Beach Post, Carlitos’ mother, Francisca Herrera, worked in Ag-Mart fields when she was 19 and pregnant with the boy. In court depositions, Herrera said that she and other workers were exposed to pesticides repeatedly when chemicals drifted from adjacent fields. Herrera also worked in fields were pesticides had been recently applied. According to Post reporters John Lantigua and Christine Stapleton, the Herreras’ complaint asserted that “at least three of the chemicals used were mutagenic, which means they had caused deformities in lab animals during testing.”
Although major birth defects like those suffered by Carlitos are thought to be rare in the farmworker community, advocates worry about the frequent use of chemicals, some of which are carcinogenic. Scientific studies have suggested that children with their smaller body weight and developing neurological and endocrine systems are more vulnerable to pesticides than adults. That’s just one of the reasons that the National Consumers League, through its leadership role in the Child Labor Coalition, is fighting to change child labor laws to close loopholes that allow kids in agriculture to work at younger ages and for longer hours than kids in other industries. We are working closely with Congresswoman Lucille Roybal-Allard (D-Calif.) in support of the CARE Act (the Children’s Act for Responsible Employment), her legislative remedy to end the discrimination against the children of farmworkers. If a 12-year-old is not allowed to work for wages in an air-conditioned office, why should he or she be allowed to work in 100-degree heat in pesticide treated fields? (Our proposed legislative changes would not impact family farms where children work for their parents.)
Terms of the settlement between Ag-Mart and the Herrera family were not disclosed, but published reports speculated that millions of dollars will go toward the care of Carlitos. Ag-Mark has stopped using the three pesticides that health experts feared caused the mutations.
If you want to support NCL’s Child Labor coalition efforts, become a member of the league and make a contribution to our work.
April 2, 2008
Contact: 202-835-3323, media@nclnet.org
Washington, D.C. — Consumers concerned about financing a new home in today’s uncertain housing market should start with a trip to MortgageTown, a new Web site (www.mortgagetown.org) launched today by the National Consumers League to help prospective buyers better understand the benefits and risks of homeownership.
“Many consumers are understandably confused about the mortgage process and what it takes to buy – and keep – a home,” said Sally Greenberg, Executive Director of the National Consumers League (NCL). “MortgageTown is a user-friendly and reliable resource where consumers can become better versed in the process of getting a mortgage and what pitfalls to avoid as they head down that road. With millions of homeowners rightfully concerned about predatory lenders, fraud, and foreclosure, it’s critically important that both current and future homeowners are educated, prepared, and protected.”
MortgageTown walks consumers through nine essential steps to financing a home. Aspiring homeowners learn how to choose the right loan, close on a home, protect themselves from fraud and predatory lenders, and prevent foreclosure. In addition to translating certain technical real estate jargon into consumer-friendly language, MortgageTown also provides direct Web links to credible sources that can help to explain inspection, closing, fraud prevention, loan options, and many other important aspects of home financing. The site also provides access to a national database where homeowners can find and track the identity of the mortgage company servicing their loan.
Mortgage Town also is a place for homeowners facing the prospect of foreclosure.
“The most pressing question for homeowners going through foreclosure is who to go to for help in working out their payments in order to keep their home,” Greenberg said. “There is only one entity who can work out a plan for them and that is the mortgage company handling their loan. Homeowners may be able to prevent foreclosure by contacting their mortgage company early and working out a plan. This site provides a quick and free way to find out the identity of their mortgage company through MERS® ServicerID.”
###
About the National Consumers League
Founded in 1899, the National Consumers League is America’s pioneer consumer organization. Its mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. NCL is a private, nonprofit membership organization. For more information, visit www.nclnet.org.
Unless you’ve been asleep the last couple of years, you’ve probably heard that we’re in the midst of a foreclosure crisis, people are abandoning homes they can no longer afford, and the rest of the economy isn’t looking so good either.
Prices for food, gas and healthcare – the most basic items – have increased by more than nine percent since 2006, according to The Washington Post.
With cities experiencing the highest number of foreclosures these days (Detroit, Stockton, and Las Vegas, you’re at the top of a sad list) offering foreclosure bus tours, things are actually looking better in some ways for people interested in buying a home.
But how can new homebuyers avoid the mistakes that are costing millions of Americans their dream homes? NCL has created a step-by-step guide, www.mortgagetown.org, which we’re launching today, to walk new homebuyers through the complicated process of making their dream of owning a home come true.
Finding the right loan, reading through and understanding all of the paperwork, closing the deal and maintaining the mortgage is enough to intimidate any prospective buyers. In addition to helping consumers through these steps, MortgageTown helps homebuyers:
Our site also has a ton of practical resources to help homeowners make sense of it all:
NCL reminds homeowners who are worried about holding onto their homes that there is help out there. Here are a few nonprofit groups, associations and government agencies you can contact:
April 1, 2008
Contact: 202-835-3323, media@nclnet.org
Washington, DC – Debit cards are convenient and safer to carry than cash, and they’re more widely accepted by merchants these days than personal checks. But just because they look and feel like a credit card doesn’t mean they work exactly like one, and not understanding the differences could cost you, warns tips featured this month in the National Consumers League’s “2008 Consumer Calendar: Do We Have Tips for You!”
NCL teaches consumers how debit cards work and how to use them wisely with tips, such as:
The nation’s oldest consumer advocacy organization, NCL works to educate people about how to make wise decisions in today’s marketplace. Each month, NCL’s Web site, www.nclnet.org, will feature the calendar and tips for the month. Covering a range of subjects from medication safety, to avoiding scams, the tips are sponsored by major companies, government agencies, and organizations. The April tips about debit cards were sponsored by Visa and its Practical Money Skills for Life program.
The print version of the calendar was distributed to consumers free of charge through agencies and organizations around the country. There are no printed copies of the calendar remaining.
###
About the National Consumers League
Founded in 1899, the National Consumers League is America’s pioneer consumer organization. Its mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. NCL is a private, nonprofit membership organization. For more information, visit www.nclnet.org.
Today may be April Fool’s Day, but we have other things on our minds. In just two weeks from today, the 2008 National LifeSmarts Champions will be determined. State teams from across the country will have endured three days of grueling competition and exploring Minneapolis (our 2008 host city), and they’ll be on their way back home.
Today, which kicks off national Financial Literacy Month, seems like a good a time to offer three cheers to the people who make LifeSmarts the exciting, challenging, and rewarding program it is. In honor of all the teen participants and adult volunteers who devote weeks or even months of their school year to our LifeSmarts program: here’s to you!
Here’s to you, volunteer state coordinators! You are the backbone of our program, and you help spread the reach of LifeSmarts into the nooks and crannies of more than 40 schools across the country. We couldn’t do it without you!
Three cheers for you, coaches and assistant coaches! You are dedicated, giving teachers, parents, and community leaders. You are our program’s cheerleaders, encouraging students to perform at new heights. Pat yourself on the back!
You rule, LifeSmarts participants! You are wise youths, empowering yourselves with the consumer knowledge that your parents should envy. You’re going to enter the real world with an insider’s knowledge. Here’s to you!
And to our program sponsors, thank you for your ongoing, generous support. You’ve enabled our program to thrive and grow. Thank you!
Happy Financial Literacy Month, everybody! See you in Minneapolis!
The work of the National Consumers League is making a difference in people’s lives across the country. Meet some of the consumers touched by our programs.
Read about NCL’s impact
Paige, 55, a Nashville wife and mother of two, answered an employment ad for secret shoppers. Before sending payment to the scammers, she reached out to NCL.
Read about NCL’s impact
A grease fire flared up in Decklan’s kitchen. As his family scrambled and panicked, fearing that the whole house might erupt in flames, Decklan remained calm. He hurried over to the pantry, grabbed some baking soda, and dumped it on the fire quickly extinguishing the blaze.
Read about NCL’s impact
Cincinnati resident Charles, 45, lost his computer business — and health insurance— during a time of economic downturn. A diabetic, Charles was now unable to afford his medication. He stopped taking it which made him seriously ill and put his life at risk.
Read about NCL’s impact
Jeremy is a fast-food worker who has been employed at a number of Chipotle restaurants in New York City. When he was just 20 years old, he took part in an NCL research project that revealed that management practices within the fast food chain were putting workers—and food safety for customers—at risk.
Read about NCL’s impact
[gravityform id=”11″ title=”true” description=”false”]
[gravityform id=”9″ title=”true” description=”false” ajax=”true”]
PBPA Commends HHS Funding to Support Maternal and Infant Health
The Preterm Birth Prevention Alliance (PBPA), a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, applauds the U.S. Department of Health and Human Services (HHS) for awarding nearly $350 million to states across the country to improve support for safe pregnancies and healthy babies.
“For far too long, U.S. maternal health care has lagged behind that of other developed countries, particularly for women of color,” noted Sally Greenberg, Executive Director of the National Consumers League. “This additional funding will enable local health departments and nonprofits to better address the health care needs of the most vulnerable mothers and their babies.”
The funding, awarded by HHS’ Health Resources and Services Administration (HRSA), will support home visiting services, increase access to doulas, address infant mortality and maternal illness, and improve data reporting on maternal mortality.
“Maternal health care in the U.S. has consistently failed women of color,” Greenberg continued. “We applaud HHS for this additional funding that will help to improve the maternal health for all mothers and babies, especially women of color and those most at-risk.”
The funding announcement follows the release of a report by the U.S. Commission on Civil Rights which found that Native American women are more than two times more likely to die from pregnancy-related complications than white women in the U.S. This disparity was further exacerbated for Black women in the U.S., who are three to four times more likely to die from pregnancy-related complications than white women.
“In addition to expanding programs to support maternal health, we must increase representation from racially and ethnically diverse groups in research and clinical trials, particularly those studying treatment options to prevent maternal morbidity and mortality,” said Greenberg. “The need for the additional HHS funding and the report from the Commission on Civil Rights clearly illustrate how critical representative research and real world evidence are to ensuring all mothers and their babies have the same opportunity for the best possible health outcomes.”
/in Blog, Health, Prevention Blog Post
By Sally Greenberg, NCL Executive Director
While the COVID-19 pandemic has led to hardship for all Americans, it is clear that people of color have been disproportionately burdened. Across the health care continuum, addressing this disparity has become part of the broader conversation about the history of systemic racism and the underlying social determinants of health that negatively affect the mental, physical, and economic health of individuals and entire communities.
The pandemic has underscored persistent health disparities, and there is growing recognition that representation in research and clinical trials can have a profound impact on health outcomes. A lack of representation from racially and ethnically diverse groups in research and clinical trials have typically led to gaps in data, missing the opportunity to assess the full impact of various treatments and drugs across a range of populations. The collection and use of real-world research and data to inform the potential use, risks, and benefits of medical products and treatments can ultimately lead to better health outcomes, particularly for those who have been underrepresented in the past.
Existing efforts to improve inclusion
Efforts to expand diversity and representation in medical research are underway in Congress. Policymakers are encouraging the incorporation of Real World Evidence (RWE) in drug development through the recent Cures 2.0 draft legislation released by Reps. Diana Degette (D-CO-1) and Fred Upton (D-MI-6). While the status quo limits us from effectively reaching underserved populations, the proposed legislation would allow studies that include RWE for some drugs after they have been approved. At the heart of this issue is a growing appreciation that the same therapy can affect different populations in different ways, which is why Cures 2.0 supports collecting data that more accurately reflects the unique experiences and needs of patients across diverse populations.
Recognizing the potential for RWE in maternal health
The lack of representative research in the field of maternal health is undeniable, and its implications are staggering. The dismal state of maternal care in the United States reflects how our health care system has failed women of color, including by not adequately studying treatment options to prevent maternal morbidity and mortality. The need for RWE is clear when you consider the persistent disparities in health outcomes that plague minority communities.
Preterm birth and its disproportionate impact on women of color is a stark illustration of the need to make progress on representative research in maternal health. Preterm birth is the second-largest contributor to infant death in America today. Despite the tremendous physical, emotional, and financial toll that preterm birth continues to take on our country — disproportionately so on women and families of color — not enough therapeutic tools currently exist to prevent it.
Today, “17P,” the only FDA-approved treatment to help reduce the likelihood of spontaneous, recurrent preterm birth in the United States is at-risk of being withdrawn from the market in all its forms, including the branded product and five generic versions. Unfortunately there is conflicting evidence from two different clinical trials, one representative of a diverse U.S. population and another studied in a largely white population in Europe. It’s not a straightforward comparison. If 17P is withdrawn, the women most affected by preterm birth, predominantly women of color, would be left without an FDA-approved treatment option.
The FDA is considering the path forward, including additional data collection through leveraging RWE from past patient use. The success of the first (approval) trial for 17P in the impacted communities signals the importance of RWE. Continued access to 17P is, at its core, a matter of health equity. Black women must not yet again be left vulnerable to a system that historically has overlooked them.
PRETERM BIRTH PREVENTION ALLIANCE APPLAUDS FDA’S GRANTING OF HEARING FOR THE ONLY FDA-APPROVED THERAPIES TO REDUCE RECURRENT PRETERM BIRTH
WASHINGTON, DC, August 26, 2021 –
Preterm Birth Prevention Alliance a coalition of maternal and women’s health advocates dedicated to improving preterm birth outcomes in the United States and addressing its disproportionate impact on women of color, commends the U.S. Food and Drug Administration (FDA) for granting a public hearing to discuss 17P, the only FDA-approved class of branded and generic treatments to reduce preterm birth in indicated patients.
We appreciate the FDA’s willingness to hear directly from individuals facing prematurity and the providers who treat them about their experiences with 17P,” said National Consumer League’s Executive Director Sally Greenberg. “It is an important step towards better understanding variations in efficacy across diverse populations and ensuring all women have an equal chance at the best possible outcomes.”
Last week, the FDA agreed to grant Covis Pharma, the manufacturer of the branded 17P product Makena its request for a public hearing to discuss 17P. Hydroxyprogesterone caproate—or “17P”—has been approved since 2011 and is the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth in the United States. In 2020, the FDA proposed withdrawing 17P in all its forms, including the branded product and its five generic versions, based on conflicting efficacy data from two studies composed of vastly different populations, one predominantly inclusive of women in the U.S. most vulnerable to preterm birth and one not.
“Mothers and birthing people deserve access to the best possible treatments to prevent preterm birth. We cannot achieve birth equity if we study pregnant women as a monolith,” said Blythe Thomas, Initiative Director of 1,000 Days. “It is only by systematically researching the real-world, post-market impact of 17P on individuals from a variety of racial and ethnic backgrounds, while maintaining access for all affected, that we can reduce disparities in maternal and infant health.”
While the hearing date has not yet been set, the Alliance looks forward to sharing the perspectives of affected individuals and their physicians with the agency once the hearing is scheduled and will continue to advocate for at-risk moms and babies of all races and ethnicities.
###
ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE
The Preterm Birth Prevention Alliance (PBPA) is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, the 15 partners in the PBPA seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org
LEADING PATIENT ADVOCATES LAUNCH PRETERM BIRTH PREVENTION ALLIANCE TO PROTECT CRITICAL ACCESS TO THE SOLE FDA-APPROVED CLASS OF THERAPIES TO REDUCE RECURRENT PRETERM BIRTH
WASHINGTON, DC, April 20, 2021 – Today, the National Consumers League (NCL), along with a coalition of patient advocacy organizations dedicated to advancing the health of mothers and infants, announced the launch of the >Preterm Birth Prevention Alliance.
Members of the Alliance are joining forces in an effort to preserve patient access to the only Food & Drug Administration-approved class of treatments for pregnant women who have previously had an unexpected, or spontaneous, preterm birth. Together, Alliance members seek to ensure that the Food & Drug Administration (FDA) hears concerns from the full range of stakeholders about the potential risks and impact of withdrawal for at-risk pregnant women and their providers.
For the fifth year in a row, the U.S. preterm birth rate has increased (to 10.2 percent of births), and preterm birth and its complications were the second largest contributor to infant death across the country. Preterm birth also represents a significant racial health disparity, with Black women in America experiencing premature delivery at a rate 50 percent higher than other racial groups throughout the country.
However, in 2020, the FDA >proposed withdrawing hydroxyprogesterone caproate, commonly called “17P” or “17-OHPC”, the only FDA-approved class of branded and generic treatments to help prevent the risk of preterm birth in women with a history of spontaneous preterm birth. The FDA is currently determining whether to hold a hearing on the status of 17P, based on conflicting efficacy data from two studies composed of vastly different patient populations, one inclusive of women in the U.S. most vulnerable to preterm birth and one not.
“We’re fighting for a more inclusive healthcare system that gives everyone an equal chance to have the best outcomes possible,” said Sally Greenberg, executive director of the National Consumers League. “We don’t believe that removing 17P from the market without gaining a better understanding of who could benefit the most from its use is in the best interests of patients, nor their healthcare providers, particularly as there are no other approved treatment options available.”
To date, 14 organizations have joined NCL to advocate for the health interests of at-risk pregnant women and infants, including: 1,000 Days; 2020 Mom; American Association of Birth Centers; Black Mamas Matter Alliance; Black Women’s Health Imperative; Expecting Health; Healthy Mothers, Healthy Babies Montana; HealthyWomen; Miracle Babies; National Birth Equity Collaborative; National Black Midwives Alliance; National Partnership for Women & Families; Sidelines High-Risk National Support Network; and SisterReach.
“As a trained obstetrician and gynecologist, I know firsthand the impact of preterm birth on Black women and birthing people. I also know that racism – not race – is the driving factor leading the disproportionate impact of preterm birth on Black women and birthing people thereby exacerbating systemic inequities in maternal and infant health. To achieve birth equity, which is the assurance of the conditions of optimal births for all people with a willingness to address racial and social inequities in a sustained effort, we must work to protect and uphold a standard of care for spontaneous, recurrent preterm births and ensure it remains accessible and affordable for all who stand in need,” added Dr. Joia Crear Perry, founder and president of the National Birth Equity Collaborative.
The Preterm Birth Prevention Alliance is calling for the FDA to grant a public hearing to fully consider all of the data, additional research methods, and stakeholder perspectives before deciding whether to withdraw approval of this critical class of therapies. The health of America’s moms and babies warrants the utmost care and consideration.
###
ABOUT THE PRETERM BIRTH PREVENTION ALLIANCE
The Preterm Birth Prevention Alliance is a coalition of maternal and women’s health advocates who share a common concern about the state of preterm birth in the United States and the proposed market withdrawal of 17P, the only FDA-approved class of treatments to help prevent spontaneous, recurrent preterm birth. Formed in 2021 by the National Consumers League, we seek to improve preterm birth outcomes in the United States by maintaining access to safe, FDA-approved treatment options and advocating for more diverse medical research that adequately represents the experiences of women and newborns of color. Women of color need a seat at the table. To learn more, visit www.pretermbirthalliance.org.
Initial support for the Preterm Birth Prevention Alliance is provided by Covis Pharma.
MEDIA CONTACT:
Carol McKay, carolm@nclnet.org
<embed src=”https://art19.com/shows/ce489618-5918-423a-9b5f-35ce4c28ca09/episodes/2f8fa6fc-6aad-4f1f-bf13-3bdb0aa41732/embed?theme=light-custom&primary_color=%231850a3″ width=”100%” height=”300″></embed>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/c7b22520-c0aa-4718-9b59-4ee67e494547/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ab80228e-48d9-4a45-a894-a1bfc4e41c64/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ea08cbc0-f9f2-4082-9222-4e33f68b6826/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/5039453f-6008-413a-9f6b-c9be649fd26e/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/fafb46f8-6d90-4cd8-91be-616366d1b8ca/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/25f0485d-bbce-46c8-bb90-139dcf1a2e7b/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/ffbcae35-84c5-4c8b-9686-6e2c79679dd0/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/520bdd73-d142-4508-9706-d81b5c042dff/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/12354e8b-bf15-4eba-b34f-20e435df3bb7/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>
<iframe src=”https://art19.com/shows/we-can-do-this/episodes/e2091efc-d66d-49f4-aa8e-8e6249858310/embed?theme=light-custom” style=”width: 100%; height: 200px; border: 0 none;” scrolling=”no”></iframe>